SAPIEN 3 valve replacement for severe aortic stenosis with a type 0 bicuspid valve
Part of Heart & circulation clinical trials.
This study tests a new way to replace your narrowed aortic valve without open-heart surgery, using a device called SAPIEN 3. It is designed for people with a specific valve shape (Type 0 bicuspid) who have severe symptoms.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You must be 50 years old or older.
- You have severe aortic stenosis (a narrowed heart valve) that is causing symptoms, or is very severe even without symptoms.
- Your aortic valve must have a specific two-flap shape called 'Type 0 bicuspid' (confirmed by a CT scan).
- You must agree to come back for all follow-up visits after the procedure.
- You must have leg arteries that are suitable for the catheter procedure (not too blocked or twisted).
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This trial tests a newer artificial heart valve (Sapien 3) placed through a small tube in the leg, for younger people (50–70) with severe aortic stenosis. It aims to see if this less invasive option works well in this age group.
This trial studies a new “valve-in-valve” procedure to treat a failing aortic bioprosthetic valve. It may help people improve blood flow through the heart valve and reduce valve-related problems.
This study is testing a new heart valve called the SAPIEN 3 Ultra RESILIA valve for people with severe aortic stenosis. Researchers want to see how well it works and how safe it is over 10 years after a minimally invasive valve replacement procedure called TAVI.
This trial compares a less invasive valve replacement (TAVR) with traditional open-heart surgery for people with a specific type of severe aortic valve narrowing (bicuspid valve). It aims to see which approach works better for those at intermediate or low surgical risk.
This study tests whether a less invasive valve replacement (TAVI) can be done safely in hospitals that don't have a full heart surgery team on site. If you have severe aortic stenosis and are 70 or older, this trial might offer a new option with a shorter recovery than open-heart surgery.
This study tests a catheter-based procedure to replace a narrowed aortic valve without traditional open-heart surgery. It's designed for patients who are at higher risk for surgery due to age, health conditions, or anatomy.
Hear when a new Aortic Stenosis trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.